Skip to content
Disclosery

GILEAD SCIENCES, INC.: TNGX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of GILEAD SCIENCES, INC. on TNGX, newest first. How the timeline and the estimate are built.

GILEAD SCIENCES, INC. held 0 TNGX shares at 2025-12-31 per its 13F-HR filed 2026-02-12.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -4,854,443 shares

    13F-HR 0001123292-26-000164 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 4,854,443 shares
    Change vs previous 13F 0 shares

    2.28% of the 13F portfolio, value $40,777,321.

    13F-HR 0001123292-25-000642 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 4,854,443 shares
    Change vs previous 13F 0 shares

    1.94% of the 13F portfolio, value $24,854,748.

    13F-HR 0001123292-25-000364 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 4,854,443 shares
    Change vs previous 13F 0 shares

    0.56% of the 13F portfolio, value $6,650,587.

    13F-HR 0001123292-25-000217 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-12-31
    13F 4,854,443 shares
    Change vs previous 13F not available

    0.97% of the 13F portfolio, value $15,000,229.

    13F-HR 0001123292-25-000079 filed by GILEAD SCIENCES, INC.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).